Newsletter · 2026-08-24 · Ashutosh Agarwal

Fund Managers Pitch PayPal Eagle Bancorp and Both Sides of the CoreWeave Debate - Weekly Podcast Idea Digest - Week of August 24, 2026

Cross-sector best-ideas digest for the week of August 24, 2026, rounding up the specific single-name stock pitches investors, fund managers, and analysts made on podcasts from August 17 to 24.

Weekly Podcast Idea Digest

Week of August 24, 2026: Fund Managers Pitch PayPal Eagle Bancorp and Both Sides of the CoreWeave Debate

Episodes from August 17–24. This is a roundup of specific stock ideas that investors, fund managers, and analysts actually pitched on podcasts over the past seven days: a named company, a direction (buy or sell), and a reason. Everything below is someone else's opinion as expressed on a podcast, not advice. I've kept the numbers, names, and reasoning intact so you can judge each idea on its merits.

A note on the week: it was busy for single-name ideas, but none of them came from the big "idea conference" stages (Sohn, Robin Hood, Delivering Alpha, and the like), those didn't show up in the library this week. What did show up was a healthy crop of fund-manager and analyst interviews making concrete calls. One housekeeping flag on honesty: a cluster of small mining "company interviews" this week are essentially management telling their own story (investor-relations style), so I've grouped those separately and labeled them as such rather than dressing them up as independent conviction.

Here are the ideas worth knowing about.

1. An Activist Wants to Fix a Beaten-Up Bank: Eagle Bancorp (EGBN)

Source: Pitch The PM, August 20, an activist investor (a former Zions Bancorporation executive now running a new hedge fund, Westport Alpha)

This was the closest thing to a classic activist pitch this week. The manager is long Eagle Bancorp, a Washington, D.C.-focused commercial bank. He bought in around $16–17 in July 2025; the stock is now about $26 (up roughly 60% in a year), and he thinks it can earn about $6 a share by 2028.

The story, in plain terms: the bank got into trouble by lending too much to one thing, office buildings. It had over $1 billion of office loans on a roughly $7 billion loan book, heavily concentrated in D.C. just as the "DOGE" federal cost-cutting made that market shaky. When the bank finally set aside a big reserve for expected loan losses (a few hundred million dollars), the market panicked and the stock collapsed, but he and a colleague had independently modeled the losses and concluded the reserve was actually adequate:

"We think you're there. And the market didn't believe them. And so the stock collapsed... We bought more, frankly."

His fix is governance, not financial engineering: split the combined chairman-and-CEO role, refresh the board with people who have cleaned up troubled banks before (he specifically recommended a former chief risk officer of Zions who worked through the 2008 crisis), and stop making the kind of giant single loans ("$30 to $100 million") that a bank Eagle's size shouldn't be making. His analogy for why current management can't be the ones to fix it:

"The person that I used to build my home is not the same person that I would use to clean up a disaster if I've had a mudslide that ran into the house."

He describes himself as a "constructive" activist who engages privately first (Eagle was receptive, he says), keeps any single activist position capped at ~10% of his fund, and gives it about a 36-month runway (24 on the low end, 48 on the high). Worth remembering this is a bank thesis, so it lives or dies on credit: if D.C. office loans deteriorate further, the "adequate reserve" call is the whole ballgame.

2. A Turnaround Investor's Biggest Bet: PayPal (PYPL)

Source: Hedge Fund Tips with Tom Hayes, August 19, Tom Hayes, Great Hill Capital

Tom Hayes (who says his fund has averaged well over 40% a year for three years) walked through why PayPal is one of his largest positions. He started buying around $60, the stock fell to $39 when the CEO changed, and he averaged his cost down to about $49 ("buying till our fingers bled"). It's now around $60.

His case is that the market wrote PayPal off for the wrong reason. People say "I haven't used PayPal in years", but PayPal owns Braintree, the invisible plumbing behind Uber, DoorDash, Ticketmaster, and Airbnb payments. Braintree is lower-margin, so as it grew, PayPal's overall margins fell and the multiple collapsed from ~20x earnings to about 8x at the low. Today he pegs it near 11x forward earnings. The numbers he leans on:

• At least $6 billion of free cash flow this year, with 100% of it going to buy back stock, enough to retire ~15% of shares in one year.
• Venmo, growing ~20% a year, which he thinks could be spun off.
• A buy-now-pay-later business also growing ~20% (a direct competitor to Affirm).
• A hidden advertising business: 439 million active users and "30 years of... demographic data" that he thinks could add $2 billion+ of free cash flow over three years, "not even priced in."

He also likes the incentives: CEO Enrique Lores (who ran a four-bagger turnaround at HP) gets his full payout only above $120 a share. Hayes frames his whole style as "cheap with a catalyst," not cheap for its own sake: "You don't want to hire the arsonist to put out the fire."

His single best stock for the next five years: Dentsply Sirona (XRAY), the dental-equipment maker. It's down 85–90%, US dental visits are still below pre-COVID levels, and he thinks it's "a GDP grower with a lot of operating leverage" that "can be a multi-bagger over the next three to five years as visits normalize."

Other Hayes calls in the same episode: long Canada Goose (broadening from $1,500 parkas to T-shirts and rainwear, plus a China recovery), long Comstock Resources (lowest-cost US natural-gas producer, Jerry Jones owns 71%, sub-$4B market cap, an AI-power-demand play), and long Alibaba. On the short/avoid side: fade Micron and memory ("very cyclical... priced in all of the excessive demand"), pass on Nvidia, Tesla, and SpaceX.

3. The Under-the-Radar Way to Play the AI Boom: Lam Research (LRCX)

Source: Full Signal, August 19, Jack Kuykowski, macro strategist (Farley Associated Research)

Kuykowski is broadly bullish on AI for the "next 18 to 24 months" (while admitting the bears may well be right in five to ten years, because the spending may not earn its keep). His high-conviction 12-month pick is Lam Research, a semiconductor-equipment company, and his angle is that it's a hidden "razor-and-blade" business:

"They have the highest percentage of recurring revenue. So basically they have a segment called customer support where they sell software subscriptions... ongoing consulting agreements and spare parts for old machines. That is a very high margin business."

His comparison is to Gillette (sell the razor, profit on the blades) or Otis elevators (sell the elevator, profit on decades of maintenance), except, unlike Otis, Lam is riding a genuine boom rather than a finished one. Lam is also the most memory-exposed of the big equipment names, which he turns into a clever "heads I win" argument: even if China floods the world with cheap memory chips and pops the bubble, "to pop that bubble, they have to buy so much equipment and they're going to buy it from LAM." The stock is already up ~60–70% this year, but he notes many of his readers had never heard of it, which he reads as a sign it isn't over-owned yet.

On the short side he mentioned Cerebras (a past winning short), shorting SpaceX (he admires Musk but thinks orbital data centers are far further out than promised), and holding put options on Meta as portfolio insurance because he thinks Meta is "spending the most wastefully." His preferred commodity play alongside all this is silver via Wheaton Precious Metals rather than the miners.

4. A Long and a Short From the Same Desk: Harrow (HROW) Up, Celsius (CELH) Down

Source: Telltales (Weekend Update), August 23, a cash-flow-focused markets podcast (AI-produced)

Two clean single-name calls here, both built around balance sheets.

Long Harrow (HROW): an eye-care pharma company, and the one name on their list they say they actually own. It "just put up the quarter the thesis needed": Q2 revenue of $71 million, up 60% from the prior quarter (and 11% year-over-year), with its VEVYE product contributing $29 million. Management reiterated full-year guidance of $350–365 million in revenue and $80–100 million of adjusted profit, and new data showed its IHEZO product delivered "about 58% less patient-reported discomfort" after eye injections. The catch they're honest about: Harrow is levered 10.5 times free cash flow, so "60% sequential growth on a balance sheet that tight is a good problem, right up until it's the only problem."

Bearish on Celsius (CELH): the energy-drink maker. The problem is that the growth is all borrowed: Q2 revenue was $818 million, up 11%, but every dollar of that growth came from its Alani Nu acquisition (which did $364 million and grew 21%), while the core Celsius brand shrank about 12%. On top of that, the president and COO (a former PepsiCo executive) walked out in a reshuffle that also brought in a new chief commercial officer and a new "chief business transformation officer", "three C-suite seats and a three-brand playbook for a company that was a one-brand growth story 18 months ago."

The same episode was skeptical of a few big names on valuation: Charter (CHTR) trading under 4x forward earnings with revenue going backwards and debt at 10x free cash flow ("the market pricing real risk that the earnings don't survive the debt"), and Tesla (TSLA) at "230 times trailing free cash flow" just as Nevada approved robo-taxi permits for Tesla, Uber, and Waymo all at once ("whatever exclusivity anyone was underwriting in that market, a regulator just deleted it in an afternoon").

5. The Week's Clearest Disagreement: CoreWeave (CRWV)

Two podcasts took opposite sides of the same AI-infrastructure name in the same week.

The bull (as a trade): Jay Singh on The David Lin Report, August 17. Singh, who runs a special-situations strategy, bought CoreWeave and its peer Nebius (NBIS) into earnings and both "crushed." He was especially enthusiastic about Nebius: Q2 revenue of $582 million, up 454% year-over-year, adjusted profit of $236 million, AI-cloud revenue up 514%, positive operating cash flow, and, crucially, not much debt, unlike CoreWeave. Management, he said, could "sell its entire 2027 capacity today." Note he explicitly framed the CoreWeave and memory buys as short-term trades, "not for long term."

The bear (long term): The Canadian Investor, August 20. Here the same CoreWeave got taken apart on its balance sheet. The summary: "one of the most exciting income statements you've seen, but one of the most terrifying balance sheets." Revenue grew 112% with a $104 billion backlog, but:

• Debt is near $35 billion against about $5 billion of cash, with capital spending guided to $35–39 billion this year.
• The company guides to roughly $1 billion of operating income, meaning it's issued about $35 of debt for every $1 of operating income it generates.
• Interest costs alone were north of $640 million in a single quarter, and "85% of revenue is lost to depreciation, stock-based compensation, and interest expenses," producing a headline 59% adjusted-EBITDA margin but a bottom-line margin of about -25%.

Their worry is that the expensive chips CoreWeave is buying today may not command the same rental prices in a few years as newer, cheaper (and increasingly Chinese) models arrive: "in two years you could be coming out with new GPUs, new tech, where your prices could collapse on the infrastructure you own now." Verdict: profitable outcome possible, but "in my personal opinion, no."

Put together, the two views aren't really contradictory: one is a momentum trade into earnings, the other is a multi-year solvency question. Both can be right.

6. A Special-Situations Manager's Broader Playbook

Source: Jay Singh, The David Lin Report, August 17 (same episode as above)

Beyond the AI-infrastructure trades, Singh laid out several longs worth noting:

• Uber (UBER): bought around $68 (down from ~$100, off more than 30%), trading at ~12x forward earnings, which he says it has "never traded like" before. The math: a company that used to burn "billions a year" should do ~$10 billion of free cash flow this year on a ~$150 billion market cap, growing to $13 billion by 2027 and $15 billion by 2028. He admits it'll be "choppy" given the Waymo/autonomous overhang.
• A software basket bought during the sell-offs: Datadog, ServiceNow, Snowflake, Wix, and cybersecurity names (his "biggest overweight"), bought contrarian when hedge funds were dumping software to hedge their AI longs. He's since trimmed Atlassian (TEAM) into its rally.
• A power/grid theme for the second half of 2026: the "AI pivot from chip hype to power and ROI." His logic: a data center "may not need to buy chips every single year, but they will need to buy power every year." He mentioned Vistra (VST) among power names he likes.

Useful context he gave: much of this year's whipsaw traces to the July blowup of Leopold Aschenbrenner's AI-focused fund (Situational Awareness), whose public book Ken Griffin's Citadel acquired after heavy losses, forced selling that made quality software and memory names briefly very cheap.

7. The Steady-Cash-Flow Compounder: McDonald's (MCD)

Source: The Dividend Mailbox, August 20, a dividend-growth investor (Denweiler Capital / growmydollar.com)

A patient, unglamorous long. The pitch is that McDonald's isn't really a hamburger company, it's a rent-and-royalty machine. Of ~$27 billion in 2025 revenue, the franchise side throws off $10.5 billion from rent and $6 billion from royalties (royalties recently raised to 5% for new franchises), producing net income of about $8.5 billion (30% of revenue) with return on invested capital consistently in the high teens (~17%).

The dividend math: earnings per share have gone from ~$5 a decade ago to a run rate near $12, the dividend from $3.44 to a $7.44 run rate (about 7% annual growth), with the payout ratio actually falling to 60%. He builds a simple 10-year model showing that if the 7% dividend growth continues, an investor collects ~$102 in dividends and the stock reaches ~$455, "slightly more than a 100% return," i.e., a double.

The discipline is where it gets interesting: the stock is around $273, at ~19x next year's earnings, which he calls "about as cheap as it's been in more than five years." But he's not backing up the truck yet: he'll "start buying a little bit" below $270 and only make it a full position below $250–260, where the cash-flow yield clears his hurdle. On the GLP-1 weight-loss-drug risk, his view is that management (deep bench from PepsiCo and P&G) will adapt the menu, and he'd rather own MCD than Nvidia for a forced 10-year hold: "Cash flow drives the bus and just stay on the bus."

8. The Comeback Trade Nobody's Watching: Peloton (PTON)

Source: Motley Fool Hidden Gems Investing, August 21, Jim O'Brien

A contrarian long on a stock down 95% from its COVID peak that "most people assume is a dead business." His argument is that the market missed a genuine turnaround under CEO Peter Stern (who came from subscription businesses at Apple and Ford, ~18 months in the seat). The old Peloton torched $3 billion on inventory chasing hardware sales and nearly went bankrupt. Now:

• It produced $378 million of free cash flow in the most recent fiscal year, on top of $324 million the year before.
• It sits on ~$1.2 billion of cash against ~$1.3 billion of debt, nearly debt-neutral.
• A big refinancing is expected in September ("no investment banker wants to work in August"), after which management is promising at least $350 million of free cash flow.
• The stock trades at under 7x trailing free cash flow: "you don't need a lot of growth at seven times free cash flow."

The co-hosts pushed back gently that Peloton still needs another growth engine ("if we could just hang on till the next pandemic"), so treat this as a balance-sheet-cleanup thesis, not a return-to-glory one.

9. The Bear Case on a Former Darling: Domino's Pizza (DPZ)

Source: The Investor's Podcast / The Intrinsic Value Podcast, August 20 & 23, Kyle Grieve & Shawn O'Malley

A thorough, honest bear case (they went in interested and came out skeptical). The core problem is that growth has stalled: revenue has compounded at just 3% since 2022, versus 11% in the prior decade, and Q2 2026 same-store sales were +0.1% in the US and -0.1% internationally. That justifies the multiple falling from over 40x earnings in 2020 to about 20x today, and they're not convinced it should stop there. Their worries stacked up:

• Leverage can run up to 5.5x, uncomfortable for a business with slowing growth, and a slide could make lenders tighten the "generous debt covenants" in Domino's securitized structure.
• Insider behavior: no open-market insider buys they could find in two years, despite multiple 30%+ drawdowns (and a recent 39% one): "It would be really great to see insiders taking advantage of this alongside other shareholders."
• GLP-1 and health trends pulling demand away from "foods that aren't as nutritious."
• Delivery aggregators (Uber, DoorDash) squeezing the margins on what used to be Domino's own delivery advantage, with none of the switching-cost moat of a business like a cell-tower company.

The memorable line: "I'm hesitant to say that this business won't be around in the next few years. But if I look out maybe 20 years from now, I would say that I have zero conviction in saying that this business will still be around."

10. A Basket of Cheap Energy Small-Caps

Source: The KE Report (Weekend Show), August 22, Dan Steffens, Energy Prospectus Group

With oil prices firming, Steffens made the case that money rotates from the big, well-known energy names down into smaller producers that are "free cash flow positive," several "trading below book value" with "pristine balance sheets." His specific names:

• Baytex (BTE): Canadian, sold its South Texas assets to pay off nearly all debt, now 81–82% weighted to oil, pays a ~1.5% dividend, "at least 50% upside" on his valuation.
• Riley Exploration Permian (REPX): a US pure-Permian play focused on shallower, cheaper zones, 4.4% dividend yield, "a pretty steep discount to my valuation."
• Crescent Energy: "an absolute screaming buy"; trading around $13–14 versus his ~$25 valuation ("it's a double"), and Wells Fargo's top energy analyst recently raised his target from $16 to $24.
• Rubellite Energy: a heavy-oil producer (CEO Sue Riddell Rose), his top performer up 91% year-to-date with "at least 50% upside" left, positioned for tight US diesel supply.
• Devon Energy (DVN): post-Coterra merger, now the second-largest US oil-and-gas producer, ~$47 versus his $64 valuation, with over $1 billion of merger savings.
• Matador Resources (MTDR) and SM Energy: quality Permian operators he sees trading well below his valuations.

Fair caveat: Steffens runs a subscription research service and openly likes promoting under-covered names, so treat the price targets as one enthusiastic analyst's, not consensus.

Also Heard This Week (Quicker Hits)

• The "gentleman activist" on his method: Alex Roepers, Atlantic Investment (Behind the Balance Sheet, August 20). More a masterclass in approach than a single pitch: he runs concentrated positions in overlooked mid-caps, engages management politely but firmly, and keeps his activism "liquid" (he can always sell). The forward-looking nugget: he's "very keen on going back into housing-materials companies that are at low multiples on low earnings," betting that as ultra-low mortgages reset in 2027–28, US existing-home sales recover from a depressed ~4 million (versus a normal ~6 million) and drag paint, carpet, and bathroom demand up with them.
• Income and REIT picks. On The Morning Filter (August 17), a Morningstar analyst flagged Energy Transfer (ET) (4-star, ~12% discount, 6.5% yield, a natural-gas-for-data-centers play), Equity Residential (EQR) (~18% discount), and Sun Communities (SUI). On Dividend Stockpile (August 18), the pitch was three REITs: Realty Income (O), Kimco (KIM) (record 96.4% occupancy), and Mid-America Apartments (MAA) (contrarian on the Sunbelt apartment supply wave rolling over).
• Scorpio Tankers (STNG) (Equity Mates, August 19): an investor named Vishal likes it on a single-digit P/E, strong dividend, and debt reduction, taking extra conviction from a reported Michael Burry purchase.
• Google (GOOGL) and Amazon (AMZN) (The Intrinsic Value Podcast, August 19): two investors defended their biggest winners: one is up ~100% on Alphabet bought at $150–190 ("a fantastic business at a fair price" despite AI-search fears), the other likes Amazon's "asymmetric AI upside" through AWS and custom chips.
• The Moderna/Merck melanoma pop (MRNA, MRK). Positive Phase 3 melanoma-vaccine data drove a huge one-day move and dominated several shows (Closing Bell, Bloomberg Intelligence, August 19). The analyst tone was cautious, not celebratory: Bernstein's Courtney Breen called the combined ~$40–50 billion in market-cap gains "momentum-driven rather than fundamentally justified" (peak melanoma sales estimated near $1.2 billion), and Bloomberg's Sam Fazeli flagged short-covering, data-quality questions, and manufacturing feasibility for a personalized therapy.
• Mining "company interviews" (label with care). Several junior miners told their own stories this week: Defense Metals (rare earths), Namibia Critical Metals, Asante Gold, Capitan Silver, and a lithium discussion on Rock Stock Channel. These are management/IR presentations, not independent investor theses, so I'm listing them as color rather than conviction calls.